相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targetable fusions of the FRK tyrosine kinase in ALK-negative anaplastic large cell lymphoma
G. Hu et al.
LEUKEMIA (2018)
Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes
Poonam K. Panjwani et al.
HUMAN PATHOLOGY (2018)
EMMPRIN (CD147) is induced by C/EBPβ and is differentially expressed in ALK plus and ALK- anaplastic large-cell lymphoma
Janine Schmidt et al.
LABORATORY INVESTIGATION (2017)
PD-L1 is commonly expressed and transcriptionally regulated by STAT3 and MYC in ALK-negative anaplastic large-cell lymphoma
V. Atsaves et al.
LEUKEMIA (2017)
Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma
W. Robert Liu et al.
BLOOD (2017)
DUSP22 and TP63 rearrangements predict outcome of ALK-negative anaplastic large cell lymphoma: a Danish cohort study
Martin Bjerregard Pedersen et al.
BLOOD (2017)
Identification of a new subclass of ALK-negative ALCL expressing aberrant levels of ERBB4 transcripts
Irene Scarfo et al.
BLOOD (2016)
Genetics of anaplastic large cell lymphoma
Yu Zeng et al.
LEUKEMIA & LYMPHOMA (2016)
The role of the ALK receptor in cancer biology
B. Hallberg et al.
ANNALS OF ONCOLOGY (2016)
Integrated mate-pair and RNA sequencing identifies novel, targetable gene fusions in peripheral T-cell lymphoma
Rebecca L. Boddicker et al.
BLOOD (2016)
Methylome analysis reveals alterations in DNA methylation in the regulatory regions of left ventricle development genes in human dilated cardiomyopathy
Bong-Seok Jo et al.
GENOMICS (2016)
Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells
M. Pizzi et al.
LEUKEMIA (2016)
Cyclin D1 expression in peripheral T-cell lymphomas
Joo Y. Song et al.
MODERN PATHOLOGY (2016)
Molecular alterations and tumor suppressive function of the DUSP22 (Dual Specificity Phosphatase 22) gene in peripheral T-cell lymphoma subtypes
Pierre Melard et al.
ONCOTARGET (2016)
Insights into the Pathogenesis of Anaplastic Large-Cell Lymphoma through Genome-wide DNA Methylation Profiling
Melanie R. Hassler et al.
CELL REPORTS (2016)
Anaplastic Large Cell Lymphomas: ALK Positive, ALK Negative, and Primary Cutaneous
Xiaoming Xing et al.
ADVANCES IN ANATOMIC PATHOLOGY (2015)
Progress in the identification of subgroups in ALK-negative anaplastic large-cell lymphoma
Rebecca L. Boddicker et al.
BIOMARKERS IN MEDICINE (2015)
Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
Junichi Kiyasu et al.
BLOOD (2015)
Convergent Mutations and Kinase Fusions Lead to Oncogenic STAT3 Activation in Anaplastic Large Cell Lymphoma
Ramona Crescenzo et al.
CANCER CELL (2015)
Secondary cutaneous involvement by systemic anaplastic lymphoma kinase-negative anaplastic large-cell lymphoma with 6p25.3 rearrangement
Andrew L. Feldman et al.
HISTOPATHOLOGY (2015)
Primary cutaneous anaplastic large cell lymphomas with 6p25.3 rearrangement exhibit particular histological features
Arantza Onaindia et al.
HISTOPATHOLOGY (2015)
ALK-positive primary cutaneous T-cell-lymphoma (CTCL) with unusual clinical presentation and aggressive course
Ulrike Wehkamp et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2015)
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
Stephen M. Ansell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Oncogenic cancer/testis antigens: prime candidates for immunotherapy
Morten F. Gjerstorff et al.
ONCOTARGET (2015)
Expression of the Chemokine Receptor Gene, CCR8, is Associated With DUSP22 Rearrangements in Anaplastic Large Cell Lymphoma
Xiaoming Xing et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2015)
Morphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
Rebecca L. King et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2015)
Cause and Consequence of Cancer/Testis Antigen Activation in Cancer
Angelique W. Whitehurst
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 54 (2014)
ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes
Edgardo R. Parrilla Castellar et al.
BLOOD (2014)
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma
Javeed Iqbal et al.
BLOOD (2014)
A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders
Thirunavukkarasu Velusamy et al.
BLOOD (2014)
Molecular Characterization of Chronic-type Adult T-cell Leukemia/Lymphoma
Noriaki Yoshida et al.
CANCER RESEARCH (2014)
Clinical development of demethylating agents in hematology
Shyamala C. Navada et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Breast Implant-Associated Anaplastic Large-Cell Lymphoma: Long-Term Follow-Up of 60 Patients
Roberto N. Miranda et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas
Teresa Palomero et al.
NATURE GENETICS (2014)
The phosphatase JKAP/DUSP22 inhibits T-cell receptor signalling and autoimmunity by inactivating Lck
Ju-Pi Li et al.
NATURE COMMUNICATIONS (2014)
Regulation of DNA Methylation Patterns by CK2-Mediated Phosphorylation of Dnmt3a
Rachel Deplus et al.
CELL REPORTS (2014)
Chromosomal Rearrangements of 6p25.3 Define a New Subtype of Lymphomatoid Papulosis
Laszlo J. Karai et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)
The expression of ALK in mycosis fungoides, stage IA
Farah R. Abdulla et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2013)
Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas
George Vasmatzis et al.
BLOOD (2012)
ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study
I. Oschlies et al.
HAEMATOLOGICA (2012)
Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing
Andrew L. Feldman et al.
BLOOD (2011)
Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
Madhavi Challa-Malladi et al.
CANCER CELL (2011)
Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies
David A. Wada et al.
MODERN PATHOLOGY (2011)
MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
Christian Steidl et al.
NATURE (2011)
FISH-negative cryptic PML-RARA rearrangement detected by long-distance polymerase chain reaction and sequencing analyses: a case study and review of the literature
Min Jin Kim et al.
CANCER GENETICS AND CYTOGENETICS (2010)
Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell Neoplasms
Roberto Piva et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
IRF4 Gene Rearrangements Define a Subgroup of CD30-Positive Cutaneous T-Cell Lymphoma: A Study of 54 Cases
Anne Pham-Ledard et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders
Ryan A. Wilcox et al.
BLOOD (2009)
NPM-ALK Oncogenic Tyrosine Kinase Controls T-Cell Identity by Transcriptional Regulation and Epigenetic Silencing in Lymphoma Cells
Chiara Ambrogio et al.
CANCER RESEARCH (2009)
Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas
A. L. Feldman et al.
LEUKEMIA (2009)
ALK-anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified:: report from the International Peripheral T-Cell Lymphoma Project
Kerry J. Savage et al.
BLOOD (2008)
Oncogenic kinase NPM/ALK induces through STAT3 expression of immunosuppressive protein CD274 (PD-L1, B7-H1)
Michal Marzec et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Pathobiology of ALK+ anaplastic large-cell lymphoma
Hesham M. Amin et al.
BLOOD (2007)
DUSP22/LMW-DSP2 regulates estrogen receptor-α-mediated signaling through dephosphorylation of Ser-118
Y. Sekine et al.
ONCOGENE (2007)
Regulation of STAT3-mediated signaling by LMW-DSP2
Y. Sekine et al.
ONCOGENE (2006)
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target
R Chiarle et al.
NATURE MEDICINE (2005)
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project
LM Rimsza et al.
BLOOD (2004)
The oncogenic fusion protein nucleophosmin-anaplastic lymphoma kinase (NPM-ALK) induces two distinct malignant phenotypes in a murine retroviral transplantation model
C Miething et al.
ONCOGENE (2003)
NPM-ALK transgenic mice spontaneously develop T-cell lymphomas, and plasma cell tumors
R Chiarle et al.
BLOOD (2003)
Inhibition of T cell antigen receptor signaling by VHR-related MKPX (VHX), a new dual specificity phosphatase related to VH1 related (VHR)
A Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death
A Zamo et al.
ONCOGENE (2002)
分享论文
